Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads

258 ASSOCIATION OF SERUM INTERFERON-GAMMA INDUCIBLE PROTEIN 10 (IP-10) LEVELS WITH VIROLOGICAL RESPONSE TO PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN THERAPY FOR HCV GENOTYPE 1 INFECTION

10.1016/s0168-8278(10)60260-7 ◽

2010 ◽

Vol 52 ◽

pp. S108-S109

Author(s):

M. Fukuda ◽

H. Yatsuhashi ◽

I. Takahara ◽

T. Murata ◽

S. Hashimoto ◽

...

Keyword(s):

Interferon Gamma ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Hcv Genotype ◽

Inducible Protein ◽

2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS

10.1016/s0168-8278(10)61196-8 ◽

2010 ◽

Vol 52 ◽

pp. S465 ◽

Cited By ~ 4

Author(s):

I. Jacobson ◽

P.J. Pockros ◽

J. Lalezari ◽

E. Lawitz ◽

M. Rodriguez-Torres ◽

...

Keyword(s):

Response Rates ◽

Pegylated Interferon ◽

Virologic Response ◽

Interferon Alfa ◽

Genotype 1 ◽

Hcv Genotype ◽

Depression and Quality of Life Assessments in HCV Genotype-1 Patients Treated with Either Consensus Interferon (CIFN) and Ribavirin (RBV) or Pegylated Interferon Alfa-2b (PEG IFN) and Ribavirin

The American Journal of Gastroenterology ◽

10.14309/00000434-200809001-00340 ◽

2008 ◽

Vol 103 ◽

pp. S131-S132

Author(s):

John Bassett ◽

Manuel Arias ◽

Corinne Maydonovitch ◽

Maria Sjogren

Keyword(s):

Quality Of Life ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Hcv Genotype ◽

Consensus Interferon ◽

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1

10.1016/s0168-8278(09)61054-0 ◽

2009 ◽

Vol 50 ◽

pp. S382-S383 ◽

Cited By ~ 32

Author(s):

I. Jacobson ◽

P. Pockros ◽

J. Lalezari ◽

E. Lawitz ◽

M. Rodriguez-Torres ◽

...

Keyword(s):

Antiviral Activity ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Hcv Genotype ◽

Treatment Naïve ◽

775 MATHEMATICAL ANALYSIS OF CLINICAL DATA SUGGESTS THAT HCV GENOTYPE 1 HAS A HIGH CELLULAR INFECTION RATE THAT IS REDUCED BY PEGYLATED-INTERFERON ALFA-2A/RIBAVIRIN

10.1016/s0168-8278(10)60777-5 ◽

2010 ◽

Vol 52 ◽

pp. S301

Author(s):

K. Cao-Van ◽

O. Lenz ◽

H.L. De Bondt ◽

P. Vis

Keyword(s):

Infection Rate ◽

Clinical Data ◽

Mathematical Analysis ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Hcv Genotype ◽

Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-alfa-2a and ribavirin

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1263882 ◽

2010 ◽

Vol 48 (08) ◽

Author(s):

CM Lange ◽

M von Wagner ◽

J Bojunga ◽

T Berg ◽

H Farnik ◽

...

Keyword(s):

Serum Lipids ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv

1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN

10.1016/s0168-8278(12)61206-9 ◽

2012 ◽

Vol 56 ◽

pp. S473 ◽

Cited By ~ 5

Author(s):

D. McPhee ◽

P. Falk ◽

P. Fracasso ◽

J. Lemm ◽

M. Liu ◽

...

Keyword(s):

Pegylated Interferon ◽

Interferon Alfa ◽

Viral Escape ◽

Genotype 1 ◽

Hcv Genotype ◽

123 EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL

10.1016/s0168-8278(09)60125-2 ◽

2009 ◽

Vol 50 ◽

pp. S50

Author(s):

C. Hézode ◽

J. Foucher ◽

J.-P. Bronowicki ◽

V. Leroy ◽

A. Tran ◽

...

Keyword(s):

Interim Analysis ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Efficacy And Safety ◽

Genotype 1 ◽

Hcv Genotype ◽

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

Hepatology International ◽

10.1007/s12072-017-9788-z ◽

2017 ◽

Vol 11 (2) ◽

pp. 188-198 ◽

Cited By ~ 2

Author(s):

Mark S. Sulkowski ◽

Walford J. Fessel ◽

Adriano Lazzarin ◽

Juan Berenguer ◽

Natalia Zakharova ◽

...

Keyword(s):

Pegylated Interferon ◽

Interferon Alfa ◽

Phase Iii ◽

Efficacy And Safety ◽

Genotype 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naïve Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-00487 ◽

2013 ◽

Vol 108 ◽

pp. S145 ◽

Cited By ~ 2

Author(s):

Christophe Moreno ◽

Peter Ferenci ◽

Tarik Asselah ◽

Graham Foster ◽

Stefan Zeuzem ◽

...

Keyword(s):

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Chronic Hcv